Hot-Spot-Guided Generative Deep Learning for Drug-Like PPI Inhibitor Design
Heqi Sun1, Jiayi Li1,2, Yufang Zhang3,4
1State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint International Research Laboratory of Metabolic & Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China.
Hot2Mol, a novel deep learning framework, designs targeted small-molecule inhibitors for protein-protein interactions (PPIs). This approach accelerates drug discovery by generating unique, potent, and drug-like compounds for challenging therapeutic targets.
Area of Science:
- Computational chemistry
- Drug discovery
- Artificial intelligence in medicine
Background:
- Protein-protein interactions (PPIs) are critical therapeutic targets.
- Developing small-molecule inhibitors for PPIs is challenging due to their large, flat interfaces.
- Existing computational methods are limited by chemical libraries and heuristics, restricting novel drug design.
Purpose of the Study:
- To introduce Hot2Mol, a generative deep learning framework for de novo design of PPI inhibitors.
- To enable precise targeting of PPI interfaces using pharmacophoric features from hot-spot residues.
- To overcome limitations of traditional methods and explore novel chemical space for drug discovery.
Main Methods:
- Hot2Mol integrates a conditional transformer for property-constrained molecular generation.
- An E(n)-equivariant graph neural network ensures spatial alignment with PPI hot-spot pharmacophores.
- A variational autoencoder is used for sampling diverse and novel molecular structures.
Main Results:
- Hot2Mol outperforms state-of-the-art models in binding affinity, drug-likeness, and novelty.
- Generated compounds exhibit strong binding stability, confirmed by molecular dynamics simulations.
- Case studies demonstrate the design of high-affinity and selective PPI inhibitors.
Conclusions:
- Hot2Mol effectively designs target-specific and drug-like PPI inhibitors.
- The framework accelerates rational drug discovery for challenging PPI targets.
- Hot2Mol represents a significant advancement in computational drug design for PPIs.
More Related Videos
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Protein-protein Interfaces
